
Articles
-
1 week ago |
shareprices.com | Emily Parsons
Science in Sport PLC - London-based sports nutrition company - Confirms it has reached agreement on the terms of a previously-announced takeover offer from bd-capital Partners Ltd, valued at 34 pence per share in cash. This is around a 24% premium to Science in Sport's closing price of 27.5p per share on Tuesday, and values Science in Sport at around GBP82.3 million on a fully diluted basis.
-
1 week ago |
shareprices.com | Emily Parsons
Camellia PLC - Kent, England-based agriculture and engineering services firm - Notes subsidiary Goodricke Group Ltd, in which Camellia holds a 74% interest, has signed a non-binding memorandum of understanding for a proposed sale of its Leesh River tea estate. The sale is subject to due diligence, and a further announcement will be made if the disposal is completed.
-
1 week ago |
marketscreener.com | Emily Parsons
(Alliance News) - Franklin Global Trust PLC on Thursday reported a "disappointing" total return during its most recent financial year, falling significantly short of its benchmark, but looks to the future with "cautious optimism". The Edinburgh-based investor formerly known as Martin Currie Global Portfolio Trust PLC said its net asset value per share at January 31 was 382.7 pence, up 6.2% from 360.5p the year before.
-
1 week ago |
marketscreener.com | Emily Parsons
(Alliance News) - SulNOx Group PLC on Thursday said it has secured a patent covering a further eight countries in Africa from the African Regional Intellectual Property Organization. The London-based green fuel technology developer said the patent covers Gambia, Ghana, Kenya, Mozambique, Sierra Leone, Uganda, Zambia and Zimbabwe.
-
1 week ago |
ca.marketscreener.com | Emily Parsons
(Alliance News) - GSK PLC on Thursday said it has received authorisation from the UK Medicines & Healthcare products Regulatory Agency for Blenrep combinations in the treatment of adults with multiple myeloma. The London-based pharmaceutical company said Blenrep, or belantamab mafodotin, was approved for the treatment of adult patients with multiple myeloma in combination with bortezomib plus dexamethasone, for patients who have received at least one prior therapy including lenalidomide.
Journalists covering the same region

Giada Zampano
Freelance Reporter and Writer at Freelance
Giada Zampano primarily covers news in Southern Italy, particularly around Naples and surrounding areas, including Rome.

Simon Collins
Sports Reporter at Derry Journal
Simon Collins primarily covers news in County Londonderry, Northern Ireland, United Kingdom and surrounding areas.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →